Characterizing the molecular etiology of arthrogryposis multiplex congenita in patients with LGI4 mutations.
Daniel G BoothNina KozarStephen BradleyDies N MeijerPublished in: Glia (2021)
Disruption of axon-glia interactions in the peripheral nervous system has emerged as a major cause of arthrogryposis multiplex congenita (AMC), a condition characterized by multiple congenital postural abnormalities involving the major joints. Several genes crucially important to the biology of Schwann cells have now been implicated with AMC. One such gene is LGI4 which encodes a secreted glycoprotein. LGI4 is expressed and secreted by Schwann cells and binds its receptor ADAM22 on the axonal membrane to drive myelination. Homozygous mutations in LGI4 or ADAM22 results in severe congenital hypomyelination and joint contractures in mice. Recently bi-allelic LGI4 loss of function mutations has been described in three unrelated families with severe AMC. Two individuals in a fourth, non-consanguineous family were found to be compound heterozygous for two LGI4 missense mutations. It is not known how these missense mutations affect the biology of LGI4. Here we investigated whether these missense mutations affected the secretion of the protein, its ADAM22 binding capacity, or its myelination-promoting function. We demonstrate that the mutations largely affect the progression of the mutant protein through the endomembrane system resulting in severely reduced expression. Importantly, binding to ADAM22 and myelination-promoting activity appear largely unaffected, suggesting that treatment with chemical chaperones to improve secretion of the mutant proteins might prove beneficial.
Keyphrases
- induced apoptosis
- early onset
- intellectual disability
- poor prognosis
- genome wide
- type diabetes
- cell cycle arrest
- high throughput
- dna methylation
- small molecule
- signaling pathway
- transcription factor
- autism spectrum disorder
- long non coding rna
- protein protein
- skeletal muscle
- pi k akt
- single molecule
- insulin resistance
- optical coherence tomography
- genome wide analysis